JoVE Logo
Faculty Resource Center

Sign In

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture

DOI :

10.3791/57013-v

October 12th, 2018

October 12th, 2018

8,861 Views

1Department of Medicine Solna, Center for Molecular Medicine, Karolinska University Hospital, Karolinska Institutet, 2Section of Intercellular Interactions, Eunice Shriver National Institute of Child Health and Human Development, National Institutes of Health

Infection of human tissues with human immunodeficiency virus (HIV) ex vivo provides a valuable 3D model of virus pathogenesis. Here, we describe a protocol to process and infect tissue specimens from human tonsils and female genital mucosae with HIV-1 and maintain them in culture at the liquid-air interface.

Tags

Ex Vivo Infection

-- Views

Related Videos

article

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL

article

Isolation of Lymphocytes from Mouse Genital Tract Mucosa

article

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

article

Assessing the Innate Sensing of HIV-1 Infected CD4+ T Cells by Plasmacytoid Dendritic Cells Using an Ex vivo Co-culture System.

article

Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture

article

Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses

article

Ex Vivo Infection of Murine Epidermis with Herpes Simplex Virus Type 1

article

Analysis of Lymphocyte Extravasation Using an In Vitro Model of the Human Blood-brain Barrier

article

Optical Screening of Novel Bacteria-specific Probes on Ex Vivo Human Lung Tissue by Confocal Laser Endomicroscopy

article

Assessment of the Synaptic Interface of Primary Human T Cells from Peripheral Blood and Lymphoid Tissue

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved